Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1993 1
1997 2
2007 1
2008 2
2010 2
2011 1
2012 2
2013 3
2014 2
2015 3
2016 3
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
[Antitumour effects of bisphosphonates in breast cancer].
van de Ven S, Kroep JR, Hamdy NA, Sleeboom HP, Nortier HW. van de Ven S, et al. Among authors: nortier hw. Ned Tijdschr Geneeskd. 2010;154:A1951. Ned Tijdschr Geneeskd. 2010. PMID: 21083955 Review. Dutch.
Illness perceptions and quality of life in Japanese and Dutch patients with non-small-cell lung cancer.
Kaptein AA, Yamaoka K, Snoei L, Kobayashi K, Uchida Y, van der Kloot WA, Tabei T, Kleijn WC, Koster M, Wijnands G, Kaajan H, Tran T, Inoue K, van Klink R, van Dooren-Coppens E, Dik H, Hayashi F, Willems L, Annema-Schmidt D, Annema J, van der Maat B, van Kralingen K, Meirink C, Ogoshi K, Aaronson N, Nortier H, Rabe K. Kaptein AA, et al. Among authors: nortier h. Lung Cancer. 2011 Jun;72(3):384-90. doi: 10.1016/j.lungcan.2010.09.010. Epub 2010 Oct 14. Lung Cancer. 2011. PMID: 20947200
Cost effectiveness of primary pegfilgrastim prophylaxis in patients with breast cancer at risk of febrile neutropenia.
Aarts MJ, Grutters JP, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, Batman E, Muller EW, van Gastel SM, Joore MA, Borm GF, Tjan-Heijnen VC. Aarts MJ, et al. Among authors: nortier hj. J Clin Oncol. 2013 Dec 1;31(34):4283-9. doi: 10.1200/JCO.2012.48.3644. Epub 2013 Oct 28. J Clin Oncol. 2013. PMID: 24166522 Clinical Trial.
Primary granulocyte colony-stimulating factor prophylaxis during the first two cycles only or throughout all chemotherapy cycles in patients with breast cancer at risk for febrile neutropenia.
Aarts MJ, Peters FP, Mandigers CM, Dercksen MW, Stouthard JM, Nortier HJ, van Laarhoven HW, van Warmerdam LJ, van de Wouw AJ, Jacobs EM, Mattijssen V, van der Rijt CC, Smilde TJ, van der Velden AW, Temizkan M, Batman E, Muller EW, van Gastel SM, Borm GF, Tjan-Heijnen VC. Aarts MJ, et al. Among authors: nortier hj. J Clin Oncol. 2013 Dec 1;31(34):4290-6. doi: 10.1200/JCO.2012.44.6229. Epub 2013 Apr 29. J Clin Oncol. 2013. PMID: 23630211 Clinical Trial.
Randomised study of tegafur-uracil plus leucovorin versus capecitabine as first-line therapy in elderly patients with advanced colorectal cancer--TLC study.
Kroep JR, van Werkhoven E, Polee M, van Groeningen CJ, Beeker A, Erdkamp F, Weijl N, van Bochove A, Erjavec Z, Kapiteijn E, Stiggelbout AM, Nortier HW, Gelderblom H. Kroep JR, et al. Among authors: nortier hw. J Geriatr Oncol. 2015 Jul;6(4):307-15. doi: 10.1016/j.jgo.2015.05.004. Epub 2015 Jul 17. J Geriatr Oncol. 2015. PMID: 26073532 Free article. Clinical Trial.
Improved guideline compliance after a 3-year audit of multidisciplinary colorectal cancer care in the western part of the Netherlands.
van der Geest LG, Krijnen P, Wouters MW, Erkelens WG, Marinelli AW, Nortier HJ, Tollenaar RA, Struikmans H; Comprehensive Cancer Centre the Netherlands (CCCNL), Location Leiden. van der Geest LG, et al. Among authors: nortier hj. J Surg Oncol. 2012 Jul 1;106(1):1-9. doi: 10.1002/jso.23038. Epub 2012 Jan 10. J Surg Oncol. 2012. PMID: 22234959
Physical activity and survival of postmenopausal, hormone receptor-positive breast cancer patients: results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study.
de Glas NA, Fontein DB, Bastiaannet E, Pijpe A, De Craen AJ, Liefers GJ, Nortier HJ, de Haes HJ, van de Velde CJ, van Leeuwen FE. de Glas NA, et al. Among authors: nortier hj. Cancer. 2014 Sep 15;120(18):2847-54. doi: 10.1002/cncr.28783. Epub 2014 May 19. Cancer. 2014. PMID: 24840230 Free article. Clinical Trial.
19 results